1/12
07:00 am
soph
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
Medium
Report
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
1/12
07:00 am
soph
SOPHiA GENETICS verstrekt voorlopige financiële resultaten voor het vierde kwartaal en het volledige jaar 2025, geeft richtsnoeren voor 2026 en kondigt overgangsplan voor de directie aan
Medium
Report
SOPHiA GENETICS verstrekt voorlopige financiële resultaten voor het vierde kwartaal en het volledige jaar 2025, geeft richtsnoeren voor 2026 en kondigt overgangsplan voor de directie aan
1/12
07:00 am
soph
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
Medium
Report
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
1/7
08:00 am
soph
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
Low
Report
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
11/11
09:58 am
soph
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025 [Yahoo! Finance]
Low
Report
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025 [Yahoo! Finance]
11/11
09:00 am
soph
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025
Low
Report
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025
11/11
09:00 am
soph
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
Low
Report
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
11/11
08:11 am
soph
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine [Yahoo! Finance]
Low
Report
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine [Yahoo! Finance]
11/11
08:01 am
soph
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
Low
Report
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
11/11
08:01 am
soph
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
Low
Report
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
11/11
08:01 am
soph
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
Low
Report
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
11/10
08:03 am
soph
SOPHiA GENETICS (NASDAQ:SOPH) had its price target raised by analysts at BTIG Research from $6.00 to $7.00. They now have a "buy" rating on the stock.
Low
Report
SOPHiA GENETICS (NASDAQ:SOPH) had its price target raised by analysts at BTIG Research from $6.00 to $7.00. They now have a "buy" rating on the stock.
11/8
11:43 pm
soph
Sophia Genetics SA (SOPH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... [Yahoo! Finance]
Low
Report
Sophia Genetics SA (SOPH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... [Yahoo! Finance]
11/4
06:45 am
soph
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
Medium
Report
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
11/1
01:05 am
soph
SOPHiA GENETICS (NASDAQ:SOPH) was upgraded by analysts at
Wall Street Ze
Low
Report
SOPHiA GENETICS (NASDAQ:SOPH) was upgraded by analysts at
Wall Street Ze
10/21
08:00 am
soph
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
Low
Report
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025